JPS6461421A - Composition based on phosphatidyl choline and medicinal use - Google Patents

Composition based on phosphatidyl choline and medicinal use

Info

Publication number
JPS6461421A
JPS6461421A JP63166650A JP16665088A JPS6461421A JP S6461421 A JPS6461421 A JP S6461421A JP 63166650 A JP63166650 A JP 63166650A JP 16665088 A JP16665088 A JP 16665088A JP S6461421 A JPS6461421 A JP S6461421A
Authority
JP
Japan
Prior art keywords
fatty acid
phosphatidyl choline
salt solution
unsaturated fatty
dispersing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP63166650A
Other languages
English (en)
Japanese (ja)
Inventor
Ratsususoon Koore
Bengumaruku Suteiigu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JPS6461421A publication Critical patent/JPS6461421A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases or cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP63166650A 1987-07-06 1988-07-04 Composition based on phosphatidyl choline and medicinal use Pending JPS6461421A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8702784A SE457933B (sv) 1987-07-06 1987-07-06 Farmaceutisk komposition innefattande en vattendispergerad blandning av lipider, monoglycerider och fosfatidylkolin samt dess anvaendning foer framstaellning av en gastronintestinalt verksam kompostion

Publications (1)

Publication Number Publication Date
JPS6461421A true JPS6461421A (en) 1989-03-08

Family

ID=20369073

Family Applications (1)

Application Number Title Priority Date Filing Date
JP63166650A Pending JPS6461421A (en) 1987-07-06 1988-07-04 Composition based on phosphatidyl choline and medicinal use

Country Status (3)

Country Link
EP (1) EP0299937A1 (enFirst)
JP (1) JPS6461421A (enFirst)
SE (1) SE457933B (enFirst)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003506397A (ja) * 1999-08-06 2003-02-18 マックス−デルブルック−セントルム フュア モレキュラー メディツィン 埋め込み可能な有効成分デポ剤
JP2005047929A (ja) * 1998-05-13 2005-02-24 Ml Lab Plc 外科手術上の癒着を阻止するためのデキストリンを含有する組成物
WO2008084864A1 (ja) * 2007-01-11 2008-07-17 Nisshin Pharma Inc. カプサイシン受容体活性化剤及びそれを噴霧する装置
JP2013542917A (ja) * 2010-08-13 2013-11-28 コンパニ・ジェルベ・ダノン 胃上部領域のための製品

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4005711C1 (enFirst) * 1990-02-23 1991-06-13 A. Nattermann & Cie Gmbh, 5000 Koeln, De
FR2670365B1 (fr) * 1990-12-18 1993-12-24 Eurial Boisson lactee et procede pour sa preparation.
FR2714621B1 (fr) * 1994-01-06 1996-02-23 Centre Nat Rech Scient Procédé de préparation de liposomes sans utilisation de solvant organique.
JPH11513393A (ja) * 1995-10-12 1999-11-16 ジーエス ディベロップメント エービー 皮膚又は粘膜表面へのもしくは介する活性物質の投与用医薬組成物
GB0200704D0 (en) * 2002-01-14 2002-02-27 Britannia Pharmaceuticals Ltd Use of phospholipids in peritoneal dialysis
WO2004024123A1 (en) * 2002-09-16 2004-03-25 Vasogen Ireland Limited Accelerating recovery from trauma

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55153713A (en) * 1979-05-02 1980-11-29 Kureha Chem Ind Co Ltd Pharmaceutical preparation of ribosome containing active substance
DE3028074C2 (de) * 1980-07-22 1983-12-08 Kurt Kampffmeyer Mühlenvereinigung KG, 2000 Hamburg Verfahren zur Herstellung eines lecithinhaltigen Produktes
ATE33333T1 (de) * 1984-01-11 1988-04-15 Von Mletzko Armin Dr Diaetetikum.
IT1176916B (it) * 1984-10-10 1987-08-18 Elvira Pistolesi Composizione farmaceutica o dietetica ad elevata attivita' antitrombotica e antiarteriosclerotica

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005047929A (ja) * 1998-05-13 2005-02-24 Ml Lab Plc 外科手術上の癒着を阻止するためのデキストリンを含有する組成物
JP2003506397A (ja) * 1999-08-06 2003-02-18 マックス−デルブルック−セントルム フュア モレキュラー メディツィン 埋め込み可能な有効成分デポ剤
WO2008084864A1 (ja) * 2007-01-11 2008-07-17 Nisshin Pharma Inc. カプサイシン受容体活性化剤及びそれを噴霧する装置
JP2013542917A (ja) * 2010-08-13 2013-11-28 コンパニ・ジェルベ・ダノン 胃上部領域のための製品

Also Published As

Publication number Publication date
SE8702784D0 (sv) 1987-07-06
SE8702784L (enFirst) 1989-01-07
SE457933B (sv) 1989-02-13
EP0299937A1 (en) 1989-01-18

Similar Documents

Publication Publication Date Title
US12076333B2 (en) Lysophosphatidylcholine compositions
CA2281706C (en) Methods and compositions for reducing the incidence of necrotizing enterocolitis
JPS6461421A (en) Composition based on phosphatidyl choline and medicinal use
EP0180786A1 (en) Pharmaceutical or dietetic composition having a high antithrombotic and antiarteriosclerotic activity
UA76108C2 (en) Use of therapeutic combination of fatty acids
EP0312612A4 (en) Nutritive emulsion preparation
DE3685392D1 (de) Galenische formen mit verzoegerter verapamil-freisetzung, deren herstellung und diese enthaltende arzneimittel.
JPS6413021A (en) Lithium salt-containing pharmacological composition
DE69512929T2 (de) Salze von aminoalkoholen und diese enthaltende pharmazeutische zusammensetzungen
EP0734723A1 (en) Therapeutic composition for hyperparathyroidism of patient subjected to artificial dialysis
HUP0101248A2 (hu) Gyomor- és/vagy nyombél-adhezív gyógyászati készítmények
Krawitt et al. The role of intestinal transport proteins in cortisone-mediated suppression of Ca2+ absorption
Manitius et al. Some observations on the influence of a magnesium-deficient diet on rats, with special reference to renal concentrating ability
ATE227304T1 (de) Tetraetherlipide und diese enthaltende liposomen sowie deren verwendung
PT682879E (pt) Produto alimentar dietetico com acidos gordos de cadeia media e sua utilizacao
Hay et al. Essential fatty acid restriction inhibits vitamin D-dependent calcium absorption
Tichelaar et al. The effect of dietary iron deficiency on the fatty acid composition of plasma and erythrocyte membrane phospholipids in the rat
DE2844861A1 (de) Diaetetisches lebensmittel zur oralen oder kuenstlichen ernaehrung und verfahren zu seiner herstellung
NO20002045L (no) FremgangsmÕte for øking av konsentrasjonen av konjugert linolsyre i melk og/eller vevfett av en drøvtygger
Galibois et al. Net appearance of amino acids in portal blood during the digestion of casein or rapeseed proteins in the pig
DE2640707A1 (de) Gewinnung von im darm resorbierbaren protein- und peptidloesungen
JPS6439939A (en) Fat-containing composition and production thereof
JPS6416715A (en) Intragastric floating pharmaceutical
JPS57128624A (en) Preventive and remedy for disease caused by srs-a
WO1995005752A1 (en) Reduced absorption of fatty acids